Skip to main content
Scholar Rock Holding Corp logo

Scholar Rock Holding Corp — Investor Relations & Filings

Ticker · SRRK ISIN · US80706P1030 LEI · 549300Z1FLPGL4OWJ459 US Professional, scientific and technical activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2022-05-26 Director's Dealing
Country US United States of America
Listing US SRRK

About Scholar Rock Holding Corp

https://scholarrock.com/

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company that discovers, develops, and delivers therapies for serious diseases, with a focus on neuromuscular disorders. The company's scientific approach is centered on selectively targeting protein growth factors in their latent, inactive state. This proprietary platform aims to modulate biological functions with high specificity, representing a novel method compared to traditional approaches that target already activated proteins. Founded on pioneering research from Harvard Medical School and Boston Children's Hospital, Scholar Rock is developing a new class of medicines to address the underlying causes of disease.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2022-05-26 English
10-Q
Interim / Quarterly Report Q1 2022
2022-05-16 English
SCHOLAR ROCK HOLDING CORPORATION 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 16, 2022, reporting the issuance of a press release announcing financial and operating results for the quarter ended March 31, 2022. The text explicitly states that the press release is furnished as an exhibit and that the Form 8-K itself is a current report. The document does not contain the full financial results or detailed financial statements but rather announces the results via a press release. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. The document length is 3478 characters, which is relatively short and consistent with an earnings release announcement rather than a full interim or annual report. Therefore, the correct classification is Earnings Release (ER).
2022-05-16 English
Regulatory Filings 2022
Regulatory Filings
2022-04-14 English
DEFA14A
Remuneration Information Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or additional materials related to a shareholder meeting. It includes voting instructions for the Annual Meeting, details about director elections, and ratification of the independent auditor. The text explicitly mentions 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934' and 'Definitive Additional Materials.' This type of document is classified as Remuneration Information (DEF 14A) because it relates to proxy materials including director elections and compensation-related voting matters. The document length is under 5,000 characters and is a proxy solicitation material, not a full report or announcement of a report publication. Therefore, the correct classification is DEF 14A with high confidence.
2022-04-13 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.